Cargando…

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a

BACKGROUND AND AIMS: Glycogen storage disease (GSD) type 1a is an inborn error of metabolism caused by defective glucose‐6‐phosphatase catalytic subunit (G6PC) activity. Patients with GSD 1a exhibit severe hepatomegaly due to glycogen and triglyceride (TG) accumulation in the liver. We have shown th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Yu, Hoogerland, Joanne A., Bloks, Vincent W., Bos, Trijnie, Bleeker, Aycha, Wolters, Henk, Wolters, Justina C., Hijmans, Brenda S., van Dijk, Theo H., Thomas, Rachel, van Weeghel, Michel, Mithieux, Gilles, Houtkooper, Riekelt H., de Bruin, Alain, Rajas, Fabienne, Kuipers, Folkert, Oosterveer, Maaike H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702155/ https://www.ncbi.nlm.nih.gov/pubmed/32083759 http://dx.doi.org/10.1002/hep.31198

Ejemplares similares

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice
por: Hoogerland, Joanne A., et al.
Publicado: (2019)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function
por: Oosterveer, Maaike H, et al.
Publicado: (2011)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Hepatic Farnesoid X-Receptor Isoforms α2 and α4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice
por: Boesjes, Marije, et al.
Publicado: (2014)

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022)

Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing
por: Rutten, Martijn G.S., et al.
Publicado: (2021)

Sirtuin activation as a therapeutic approach against inborn errors of metabolism
por: Bleeker, Jeannette C., et al.
Publicado: (2016)

Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia
por: La Rose, Anouk M., et al.
Publicado: (2021)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis
por: Heida, Andries, et al.
Publicado: (2021)

Identification of key pathways and metabolic fingerprints of longevity in C. elegans
por: Gao, Arwen W., et al.
Publicado: (2018)

High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice
por: Oosterveer, Maaike H., et al.
Publicado: (2009)

A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism
por: Blankestijn, Maaike, et al.
Publicado: (2022)

Polar metabolomics in human muscle biopsies using a liquid-liquid extraction and full-scan LC-MS
por: Schomakers, Bauke V., et al.
Publicado: (2022)

A metabolomic signature of decelerated physiological aging in human plasma
por: Janssens, Georges E., et al.
Publicado: (2023)

Exploring the therapeutic space around NAD(+)
por: Houtkooper, Riekelt H., et al.
Publicado: (2012)

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018)

Mitochondrial quality control pathways as determinants of metabolic health
por: Held, Ntsiki M., et al.
Publicado: (2015)

Identification of longevity compounds with minimized probabilities of side effects
por: Janssens, Georges E., et al.
Publicado: (2020)

Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
por: Monteillet, Laure, et al.
Publicado: (2021)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

The Role of AMPK Signaling in Brown Adipose Tissue Activation
por: van der Vaart, Jamie I., et al.
Publicado: (2021)

Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction
por: Smits, Myrthe A J, et al.
Publicado: (2023)

Skeletal muscle in healthy humans exhibits a day-night rhythm in lipid metabolism
por: Held, Ntsiki M., et al.
Publicado: (2020)

Hepatic stress associated with pathologies characterized by disturbed glucose production
por: Gjorgjieva, Monika, et al.
Publicado: (2019)

Mitochondrial response to nutrient availability and its role in metabolic disease
por: Gao, Arwen W, et al.
Publicado: (2014)

NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?
por: Connell, Niels J., et al.
Publicado: (2019)

NAD(+) to assess health in aging humans
por: Janssens, Georges E., et al.
Publicado: (2022)

Pyruvate dehydrogenase complex plays a central role in brown adipocyte energy expenditure and fuel utilization during short-term beta-adrenergic activation
por: Held, Ntsiki M., et al.
Publicado: (2018)

Short‐term protein restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose tissue
por: Dommerholt, Marleen B., et al.
Publicado: (2020)

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
por: Peeks, Fabian, et al.
Publicado: (2021)

Antibiotic use and abuse: A threat to mitochondria and chloroplasts with impact on research, health, and environment
por: Wang, Xu, et al.
Publicado: (2015)

Confounding factors from inducible systems for spatiotemporal gene expression regulation
por: Wüst, Rob C.I., et al.
Publicado: (2020)

Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism
por: Rajas, Fabienne, et al.
Publicado: (2019)

Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pp5hq4lq4751ne7fsqc5s7have